Home  /  

Attention Pharma and Biotech Companies Check Out This Advice for Attracting A New Type of Investor Continued from Investing in Sustainable Healthcare: Part 1. In part 2 of our interview with Swiss asset manager, Viopas Partners, co-founder Michael Schröter explains what pharma and biotech companies can do to ensure their…

Read More

A New Investment Trend for Pharma and Biotech Companies Investing Only in Companies that Deliver Scientific Innovation and Directly Address the Spiraling Costs of Healthcare In part 1 of our interview with the co-founders of Swiss asset manager, Viopas Partners, we discuss their vision for starting a company that will…

Read More

Feb 12

Steps for a Successful FDA Advisory Meeting

Listen to Jim DiBiasi, 3D Communications Founding Partner, and Christine Glenn, Head of Regulatory Excellence, Sanofi as they share their... View Webinar

Listen to Jim DiBiasi, 3D Communications Founding Partner, and Christine Glenn, Head of Regulatory Excellence, Sanofi as they share their insights and expertise on how to prepare for an FDA advisory committee meeting.

View Webinar

Cara Vivarelli-O’Neill brings two decades of pharmaceutical and healthcare industry experience. Washington, DC—3D Communications, LLC announced today the hiring of Cara Vivarelli-O’Neill, MPH, the former Director of Communications for North America for ViiV Healthcare.  A seasoned communications specialist, Cara brings two decades of pharmaceutical and healthcare industry experience across government…

Read More